Budesonide for Crohn's disease

391 Both Budesonide (9mg) As Well As High-Dose Eudragit-L-Coated Mesalamine (4.5g) Lead to High Remission Rates in Moderately Active Crohn's Disease Patients: A Double-Blind, Double-Dummy, Randomized, Multicenter Study

(2009) Andreas Tromm et al.   GASTROENTEROLOGY

Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease

(2008) James D. Lewis et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on Budesonide Pharmacokinetics: A Possible Role of Intestinal CYP3A4 Expression

(2008) M Ufer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy

(2008) Dawn B. Beaulieu et al.   INFLAMMATORY BOWEL DISEASES

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

(2008) Jeffrey C Barrett et al.   NATURE GENETICS

Epidemiology, genes and inflammatory bowel diseases in childhood

(2007) M.B. de Mesquita et al.   DIGESTIVE AND LIVER DISEASE